Instructions
Contact
100% satisfaction
guaranted!
We offer you a
60-day-money-back
guarantee!

If you are not fully
satisfied for
any reason
we will refund
you the full
purchase price!
 

Deutschenglish


SedaLeukin

Weight loss and lack of appetite are serious accompanying symptoms of cancer. Numerous studies show that cancer patients who eat healthy and with good appetite, react much better towards an anti-cancer treatment than underweight, cachectic patients. Malnourished patients are especially prone to infections, their wounds are slow to heal after operations. As a result they have a lower life expectancy.

The side effects of anti-cancer chemotherapy are not the sole cause for weight-loss. About 40-50% of cancer patients report weight-loss even before the cancer diagnosis. It is suspected that interleukins of the immune system like TNF-α Interleukin 1β and 6 and others play a significant role. Many tumor cells produce substances that increase the production of interleukins.

Research results about Artemisia absinthium of the past several years have demonstrated that the herb is able to curb the production of TNF-α, IL-1 β and IL-6, NF-KB iNOS. Artemeisia absinthium is recommended in European monographs for boosting appetite. Based on the pharmacology of Artemisia absinthium which is now becoming known and its traditional use as an appetite stimulant, we are confident that the following therapeutic goals can be fulfilled:

          What can you expect from SedaLeukin?

  •   Maintaining/improving the dietary condition
  •   Improvement of (subjective) quality of life
  •   Improved response to chemotherapy

Despite the fact that Artemisia absinthium is recommended in all major monographs for appetite-increase, it is all the more surprising that it has never been tested scientifically for cancer patients yet although precisely this target group is the most suitable of all. It could be speculated that it is the reluctance of the pharmaceutical industry to supply a resonably priced over-the-counter medication.

More than 80% of cancer patients use "alternative therapies" at some point during the course of their disease. Often the physician is asked for advice. Therefore, doctors should have answers on hand which are not only honest and well founded but also respect the desire of patients for "alternative therapies" and are on top of that effective, reasonably priced and safe.

          Who will benefit?


  • All leukemia, lymphoma and GI-cancer patients over 18 with unwanted weight-loss having an index of at least 50% in the Karnofsky Performance Scale.

          Who will benefit little?

  • Patients with heavy mucositis due to radio- or chemotherapy
  • Patients with surgery less than one month ago
  • Insulin-dependent diabetes and hyperthyreose patients

          Therapy and Duration


3 times 3 capsules a day for 3 months.

The other treatments of cancer patients may not be touched on.

   
 

SedaLeukin -  Instructions -  Contact